Charleston, SC -- (SBWIRE) -- 10/04/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: Orexigen Therapeutics, Inc. (NASDAQ:OREX), Eldorado Gold Corp (USA) (NYSE:EGO), Affymetrix, Inc. (NASDAQ:AFFX), New Residential Investment Corp (NYSE:NRZ).
Orexigen Therapeutics, Inc. (NASDAQ:OREX) opened its last trade at the price of $6.44. Its closing price was $6.39 after gaining 5.45% for the day. The company traded with the total volume of 2,424,203 shares, while its average trading volume remained 1.02 million shares. The beta of this stock stands at 2.08. Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the body's efforts to compensate for weight loss.
For How Long OREX will Fight for Profitability? Read This Trend Analysis report
Eldorado Gold Corp (USA) (NYSE:EGO) percentage change plunged -2.14% to close at $6.41 with the total traded volume of 4,343,993 shares, along with average volume of 7.61 million shares. The 52 week range of the stock remained $5.56 - $15.64, while its day lowest price was $6.40. The share price hit the day highest price of $6.63. Eldorado Gold Corporation (Eldorado) is a gold exploration, development, mining and production company. The Company owns and operates mines worldwide.
Has EGO Found The Bottom And Ready To Gain Momentum? Find Out Here
Affymetrix, Inc. (NASDAQ:AFFX) traded on volume of 1,230,588 shares in the last session against average volume of 1.31 million shares. The company started its trading session with the price of $6.42 and closed at $6.41 by scoring -0.77%. Affymetrix, Inc. (Affymetrix) is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets.
Why Should Investors Buy AFFX After the Recent Fall? Just Go Here and Find Out
New Residential Investment Corp (NYSE:NRZ) started its last trading session with the price of $6.50 and closed at $6.45 by scoring -0.92%. The stock traded with total volume of 1,020,071 shares, while the average trading volume remained 2.06 million shares. Day range for the stock was $6.40 - $6.53. New Residential Investment Corp., incorporated on September 26, 2013, is a real estate investment trust. The Company focuses on investing in, and actively managing, investments related to residential real estate.
Will NRZ Get Buyers Even After The Recent Rally? Find Out Here
About Today’s Penny Stocks
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)